Symbols / OGEN $0.58 +3.98% Oragenics, Inc.

Healthcare • Biotechnology • United States • ASE
OGEN Chart
About

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 2.54M
Enterprise Value -5.73M Income -9.84M Sales —
Book/sh 1.94 Cash/sh 1.94 Dividend Yield —
Payout 0.00% Employees 3 IPO —
P/E 0.02 Forward P/E -0.05 PEG —
P/S — P/B 0.30 P/C —
EV/EBITDA — EV/Sales — Quick Ratio 4.73
Current Ratio 5.64 Debt/Eq 2.75 LT Debt/Eq —
EPS (ttm) -4.56 EPS next Y -10.80 EPS Growth —
Revenue Growth — Earnings 2023-05-12 16:00 ROA -101.41%
ROE -243.94% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 4.34M
Shs Float 4.24M Short Float 18.30% Short Ratio 1.36
Short Interest — 52W High 9.60 52W Low 0.50
Beta 1.21 Avg Volume 545.03K Volume 74.54K
Target Price — Recom None Prev Close $0.56
Price $0.58 Change 3.98%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.58
Latest analyst target
3. DCF / Fair value
$-23.86
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.58
Low
—
High
—
Mean
—
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-12 TELLING FREDERICK W Director — 210 $0.94 $198
2025-12-12 TELLING FREDERICK W Director — 210 $0.94 $198
2025-06-18 ODYSSEY HEALTH, INC Beneficial Owner of more than 10% of a Class of Security — 7,044 $4.26 $30,407
2025-06-16 ODYSSEY HEALTH, INC Beneficial Owner of more than 10% of a Class of Security — 10,000 $4.27 $43,600
2024-12-11 KOSKI ROBERT C Director — 5,000 — —
2024-12-06 TELLING FREDERICK W Director — 3,597 $0.36 $1,295
2024-12-06 DUNTON ALAN WILLIAM Director — 66 $0.36 $24
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
9.36
-11.33%
10.56
-49.49%
20.90
+44.96%
14.42
Research And Development
2.39
-41.85%
4.11
-73.44%
15.49
+53.79%
10.07
Selling General And Administration
6.97
+8.15%
6.44
+18.20%
5.45
+21.71%
4.48
General And Administrative Expense
6.97
+8.15%
6.44
+18.20%
5.45
+21.71%
4.48
Other Gand A
6.97
+8.15%
6.44
+18.20%
5.45
+21.71%
4.48
Other Operating Expenses
—
—
-0.04
+71.37%
-0.13
Total Expenses
9.36
-11.33%
10.56
-49.49%
20.90
+44.96%
14.42
Operating Income
-9.36
+11.33%
-10.56
+49.49%
-20.90
-44.96%
-14.42
Total Operating Income As Reported
-9.36
+11.33%
-10.56
+49.49%
-20.90
-44.96%
-14.42
EBITDA
-9.19
+12.76%
-10.54
+48.84%
-20.60
-44.76%
-14.23
Normalized EBITDA
-9.18
+12.68%
-10.51
+48.96%
-20.60
-44.76%
-14.23
Reconciled Depreciation
—
0.00
-100.00%
0.03
-38.68%
0.04
EBIT
-9.19
+12.76%
-10.54
+48.91%
-20.63
-44.50%
-14.27
Total Unusual Items
-0.01
+47.59%
-0.03
—
—
Total Unusual Items Excluding Goodwill
-0.01
+47.59%
-0.03
—
—
Net Income
-9.84
+6.86%
-10.57
+48.84%
-20.66
-44.56%
-14.29
Pretax Income
-9.98
+5.57%
-10.57
+48.84%
-20.66
-44.56%
-14.29
Net Non Operating Interest Income Expense
-0.60
-3856.93%
0.02
-91.06%
0.18
+48.85%
0.12
Interest Expense Non Operating
0.79
+2534.87%
0.03
-2.49%
0.03
+102.55%
0.02
Net Interest Income
-0.60
-3856.93%
0.02
-91.06%
0.18
+48.85%
0.12
Interest Expense
0.79
+2534.87%
0.03
-2.49%
0.03
+102.55%
0.02
Interest Income Non Operating
0.18
+297.04%
0.05
-78.19%
0.21
+54.82%
0.14
Interest Income
0.18
+297.04%
0.05
-78.19%
0.21
+54.82%
0.14
Other Income Expense
-0.01
+47.59%
-0.03
-136.29%
0.07
+498.89%
0.01
Other Non Operating Income Expenses
—
—
0.07
+498.89%
0.01
Gain On Sale Of Security
-0.01
+47.59%
-0.03
—
—
Tax Provision
-0.14
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
-0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-9.84
+6.86%
-10.57
+48.84%
-20.66
-44.56%
-14.29
Net Income From Continuing Operation Net Minority Interest
-9.84
+6.86%
-10.57
+48.84%
-20.66
-44.56%
-14.29
Net Income From Continuing And Discontinued Operation
-9.84
+6.86%
-10.57
+48.84%
-20.66
-44.56%
-14.29
Net Income Continuous Operations
-9.84
+6.86%
-10.57
+48.84%
-20.66
-44.56%
-14.29
Normalized Income
-9.83
+6.77%
-10.54
+48.96%
-20.66
-44.56%
-14.29
Net Income Common Stockholders
-9.84
+6.86%
-10.57
+48.84%
-20.66
-44.56%
-14.29
Diluted EPS
-4.56
+90.48%
-47.88
+82.61%
-275.40
-29.11%
-213.30
Basic EPS
-4.56
+90.48%
-47.88
+82.61%
-275.40
-29.11%
-213.30
Basic Average Shares
2.16
+877.24%
0.22
+194.35%
0.07
+11.97%
0.07
Diluted Average Shares
2.16
+877.24%
0.22
+194.35%
0.07
+11.97%
0.07
Diluted NI Availto Com Stockholders
-9.84
+6.86%
-10.57
+48.84%
-20.66
-44.56%
-14.29
Other Taxes
—
—
—
0.01
Line Item Trend 2023-12-31
Total Assets
4.97
Current Assets
3.87
Cash Cash Equivalents And Short Term Investments
3.48
Cash And Cash Equivalents
3.48
Other Short Term Investments
—
Receivables
—
Other Receivables
—
Accrued Interest Receivable
—
Prepaid Assets
—
Other Current Assets
0.38
Total Non Current Assets
1.10
Net PPE
0.01
Gross PPE
0.01
Accumulated Depreciation
0.00
Properties
0.00
Machinery Furniture Equipment
0.00
Other Properties
0.01
Leases
0.00
Non Current Prepaid Assets
1.09
Total Liabilities Net Minority Interest
1.80
Current Liabilities
1.80
Payables And Accrued Expenses
1.47
Payables
1.24
Accounts Payable
1.24
Current Accrued Expenses
0.22
Pensionand Other Post Retirement Benefit Plans Current
0.01
Current Debt And Capital Lease Obligation
0.32
Current Debt
0.31
Current Capital Lease Obligation
0.01
Total Non Current Liabilities Net Minority Interest
0.00
Long Term Debt And Capital Lease Obligation
0.00
Long Term Capital Lease Obligation
0.00
Stockholders Equity
3.17
Common Stock Equity
1.58
Capital Stock
1.60
Common Stock
0.00
Preferred Stock
1.59
Share Issued
0.10
Ordinary Shares Number
0.10
Treasury Shares Number
0.00
Additional Paid In Capital
207.79
Retained Earnings
-206.22
Total Equity Gross Minority Interest
3.17
Total Capitalization
3.17
Working Capital
2.07
Invested Capital
1.89
Total Debt
0.32
Capital Lease Obligations
0.01
Net Tangible Assets
3.17
Tangible Book Value
1.58
Current Notes Payable
0.31
Preferred Stock Equity
1.59
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-9.25
-7.55%
-8.60
-17.92%
-7.29
+52.12%
-15.23
Cash Flow From Continuing Operating Activities
-9.25
-7.55%
-8.60
-17.92%
-7.29
+52.12%
-15.23
Net Income From Continuing Operations
-9.84
+6.86%
-10.57
+48.84%
-20.66
-44.56%
-14.29
Depreciation Amortization Depletion
—
0.00
-100.00%
0.03
-38.68%
0.04
Depreciation And Amortization
—
0.00
-100.00%
0.03
-38.68%
0.04
Other Non Cash Items
0.90
—
10.27
—
Stock Based Compensation
0.56
+7.69%
0.52
-49.25%
1.02
+37.00%
0.74
Operating Gains Losses
—
—
0.03
+373.22%
-0.01
Gain Loss On Sale Of PPE
—
0.00
-100.00%
0.03
+373.22%
-0.01
Change In Working Capital
-0.86
-158.94%
1.45
-27.89%
2.02
+217.55%
-1.72
Change In Receivables
-0.05
0.00
0.00
-100.00%
0.01
Change In Prepaid Assets
-1.01
-163.98%
1.57
-21.32%
2.00
+205.33%
-1.90
Change In Payables And Accrued Expense
0.20
+269.57%
-0.12
-564.38%
0.03
-85.39%
0.18
Change In Other Current Assets
0.00
-100.00%
0.01
-97.09%
0.34
0.00
Change In Other Current Liabilities
0.00
+100.00%
-0.01
+97.17%
-0.35
—
Investing Cash Flow
—
0.00
+100.00%
-0.94
-710.50%
-0.12
Cash Flow From Continuing Investing Activities
—
0.00
+100.00%
-0.94
-710.50%
-0.12
Net PPE Purchase And Sale
—
0.00
-100.00%
0.06
+155.16%
-0.12
Purchase Of PPE
—
—
0.00
+100.00%
-0.13
Sale Of PPE
—
0.00
-100.00%
0.06
+430.97%
0.01
Capital Expenditure
—
—
-1.00
-684.20%
-0.13
Net Intangibles Purchase And Sale
—
0.00
+100.00%
-1.00
0.00
Purchase Of Intangibles
—
0.00
+100.00%
-1.00
0.00
Financing Cash Flow
16.78
+180.68%
5.98
+2006.07%
0.28
+157.36%
-0.49
Cash Flow From Continuing Financing Activities
16.78
+180.68%
5.98
+2006.07%
0.28
+157.36%
-0.49
Net Issuance Payments Of Debt
-0.87
-25.90%
-0.69
-22.45%
-0.57
-0.33%
-0.56
Issuance Of Debt
2.46
0.00
0.00
0.00
Repayment Of Debt
-3.33
-380.23%
-0.69
-22.45%
-0.57
-0.33%
-0.56
Short Term Debt Issuance
2.46
0.00
0.00
0.00
Short Term Debt Payments
-3.33
-380.23%
-0.69
-22.45%
-0.57
-0.33%
-0.56
Net Short Term Debt Issuance
-0.87
-25.90%
-0.69
-22.45%
-0.57
-0.33%
-0.56
Net Common Stock Issuance
2.63
-60.52%
6.67
+684.99%
0.85
+1126.64%
0.07
Repurchase Of Capital Stock
—
—
—
0.00
Proceeds From Stock Option Exercised
—
—
—
0.00
Changes In Cash
7.53
+387.74%
-2.62
+67.03%
-7.94
+49.85%
-15.84
Beginning Cash Position
0.86
-75.17%
3.48
-69.51%
11.43
-58.09%
27.27
End Cash Position
8.40
+871.25%
0.86
-75.17%
3.48
-69.51%
11.43
Free Cash Flow
-9.25
-7.55%
-8.60
-3.70%
-8.29
+46.01%
-15.36
Interest Paid Supplemental Data
0.02
-25.06%
0.03
-2.49%
0.03
+229.29%
0.01
Common Stock Issuance
2.63
-60.52%
6.67
+684.99%
0.85
+1126.64%
0.07
Issuance Of Capital Stock
17.65
+164.60%
6.67
+684.99%
0.85
+1126.64%
0.07
Net Preferred Stock Issuance
15.02
0.00
—
0.00
Preferred Stock Issuance
15.02
0.00
—
—
Preferred Stock Payments
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category